Taylor Wealth Management Partners trimmed its position in Tabula Rasa HealthCare Inc (NASDAQ:TRHC) by 1.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 138,901 shares of the company’s stock after selling 2,376 shares during the quarter. Tabula Rasa HealthCare makes up 5.1% of Taylor Wealth Management Partners’ holdings, making the stock its 7th largest position. Taylor Wealth Management Partners owned about 0.68% of Tabula Rasa HealthCare worth $8,856,000 at the end of the most recent reporting period.
Other hedge funds have also recently modified their holdings of the company. BlackRock Inc. raised its holdings in Tabula Rasa HealthCare by 20.8% in the 3rd quarter. BlackRock Inc. now owns 2,560,710 shares of the company’s stock valued at $207,904,000 after acquiring an additional 441,203 shares during the period. Vanguard Group Inc raised its holdings in Tabula Rasa HealthCare by 6.9% in the 3rd quarter. Vanguard Group Inc now owns 967,769 shares of the company’s stock valued at $78,573,000 after acquiring an additional 62,267 shares during the period. Vanguard Group Inc. raised its holdings in Tabula Rasa HealthCare by 6.9% in the 3rd quarter. Vanguard Group Inc. now owns 967,769 shares of the company’s stock valued at $78,573,000 after acquiring an additional 62,267 shares during the period. NN Investment Partners Holdings N.V. raised its holdings in Tabula Rasa HealthCare by 45.2% in the 3rd quarter. NN Investment Partners Holdings N.V. now owns 669,800 shares of the company’s stock valued at $54,380,000 after acquiring an additional 208,604 shares during the period. Finally, Bank of New York Mellon Corp raised its holdings in Tabula Rasa HealthCare by 20.8% in the 3rd quarter. Bank of New York Mellon Corp now owns 258,613 shares of the company’s stock valued at $20,996,000 after acquiring an additional 44,551 shares during the period. 74.87% of the stock is currently owned by institutional investors.
Shares of NASDAQ TRHC traded down $1.86 during trading hours on Monday, hitting $64.14. 10,443 shares of the stock were exchanged, compared to its average volume of 211,050. The company has a current ratio of 0.49, a quick ratio of 0.46 and a debt-to-equity ratio of 0.28. The firm has a market capitalization of $1.35 billion, a price-to-earnings ratio of -1,603.50, a P/E/G ratio of 4.20 and a beta of 2.45. Tabula Rasa HealthCare Inc has a 1-year low of $28.55 and a 1-year high of $91.16.
Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its quarterly earnings results on Tuesday, November 6th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.19 by $0.07. The business had revenue of $54.42 million for the quarter, compared to analyst estimates of $52.87 million. Tabula Rasa HealthCare had a negative net margin of 13.49% and a positive return on equity of 7.63%. The firm’s revenue for the quarter was up 66.3% on a year-over-year basis. During the same quarter last year, the business posted $0.08 EPS. On average, equities research analysts forecast that Tabula Rasa HealthCare Inc will post 0.42 earnings per share for the current year.
Several research firms have weighed in on TRHC. Zacks Investment Research cut shares of Tabula Rasa HealthCare from a “hold” rating to a “sell” rating in a report on Saturday, November 10th. Benchmark began coverage on shares of Tabula Rasa HealthCare in a report on Tuesday, January 8th. They issued a “buy” rating and a $85.00 price target on the stock. BidaskClub cut shares of Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a report on Thursday, November 15th. Finally, Chardan Capital increased their price target on shares of Tabula Rasa HealthCare from $77.00 to $91.00 and gave the company a “buy” rating in a report on Wednesday, November 7th. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $82.27.
In related news, insider Andrea Carolan Speers sold 1,022 shares of the stock in a transaction that occurred on Thursday, January 3rd. The shares were sold at an average price of $58.08, for a total transaction of $59,357.76. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Samira Beckwith sold 1,733 shares of the stock in a transaction that occurred on Wednesday, December 12th. The stock was sold at an average price of $75.76, for a total transaction of $131,292.08. The disclosure for this sale can be found here. Insiders have sold a total of 63,790 shares of company stock worth $4,409,251 in the last quarter. 14.00% of the stock is currently owned by company insiders.
Tabula Rasa HealthCare Profile
Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.
Further Reading: Risk Tolerance
Want to see what other hedge funds are holding TRHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tabula Rasa HealthCare Inc (NASDAQ:TRHC).
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.